Clinical Trial Update: Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 open-label study assessing a Mimogen-based therapeutic vaccine for chronic hepatitis B has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Mimogen-based Therapeutic Hepatitis B Vaccine

Snippet

Sponsor: Chongqing Jiachen Biotechnology Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2017-01-18